| The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice |
15 |
| Physician interpretation of variants of uncertain significance |
14 |
| Hereditary gastric cancer: what's new? Update 2013-2018 |
11 |
| Recent advances in Lynch syndrome |
10 |
| Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic |
10 |
| Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Mori |
9 |
| Moving into the mainstream: healthcare professionals' views of implementing treatment focussed genetic testing in breast cancer care |
8 |
| Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European |
8 |
| Association between miR-146a rs2910164 polymorphism and specific cancer susceptibility: an updated meta-analysis |
8 |
| An exploration of genotype-phenotype link between Peutz-Jeghers syndrome and STK11: a review |
7 |
| Mutations in context: implications of BRCA testing in diverse populations |
7 |
| Implication of DNA repair genes in Lynch-like syndrome |
6 |
| Multi-gene panel testing confirms phenotypic variability in MUTYH-Associated Polyposis |
6 |
| Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk |
6 |
| p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers |
6 |
| Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history |
6 |
| Germline mutation p.N363K in POLE is associated with an increased risk of colorectal cancer and giant cell glioblastoma |
5 |
| Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge |
5 |
| TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort |
5 |
| Pancreatic neuroendocrine tumor in a patient with a TSC1 variant: case report and review of the literature |
5 |
| Metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysis |
5 |
| A retrospective review of 48 individuals, including 12 families, molecularly diagnosed with hereditary leiomyomatosis and renal cell cancer (HLRCC) |
4 |
| Heightened perception of breast cancer risk in young women at risk of familial breast cancer |
4 |
| Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687+1G > A germline mutation and review of the literature |
4 |
| Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas |
4 |
| How do clinical genetics consent forms address the familial approach to confidentiality and incidental findings? A mixed-methods study |
4 |
| The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes |
4 |
| The development of an online decision aid to support persons having a genetic predisposition to cancer and their partners during reproductive decision-making: a usability and pilot study |
4 |
| Hereditary diffuse gastric cancer: cancer risk and the personal cost of preventive surgery |
4 |
| The incidence of consecutive manifestations in Von Hippel-Lindau disease |
3 |
| Cancer patients' intentions towards receiving unsolicited genetic information obtained using next-generation sequencing |
3 |
| Issues related to family history of cancer at the end of life: a palliative care providers' survey |
3 |
| A comparison of cosegregation analysis methods for the clinical setting |
3 |
| Mutational analysis of the RB1 gene and the inheritance patterns of retinoblastoma in Jordan |
3 |
| Outcome of thyroid ultrasound screening in FAP patients with a normal baseline exam |
3 |
| Unsolicited information letters to increase awareness of Lynch syndrome and familial colorectal cancer: reactions and attitudes |
3 |
| Reminders of cancer risk and pain catastrophizing: relationships with cancer worry and perceived risk in women with a first-degree relative with breast cancer |
3 |
| Contiguous gene deletion of chromosome 2p16.3-p21 as a cause of Lynch syndrome |
3 |
| Genetic counselling of young women with breast cancer for Li-Fraumeni syndrome: a nationwide survey on the experiences and attitudes of genetics professionals |
3 |
| A multi-gene panel study in hereditary breast and ovarian cancer in Colombia |
3 |
| Development and pilot testing of a leaflet informing women with breast cancer about genomic testing for polygenic risk |
3 |
| Risk management adherence following genetic testing for hereditary cancer syndromes: a Singaporean experience |
2 |
| RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers |
2 |
| Phenotypic confirmation of oligodontia, colorectal polyposis and cancer in a family carrying an exon 7 nonsense variant in the AXIN2 gene |
2 |
| Genetic counseling referral for ovarian cancer patients: a call to action |
2 |
| Pediatric craniopharyngioma in association with familial adenomatous polyposis |
2 |
| Quality of life following prophylactic gynecological surgery: experiences of female Lynch mutation carriers |
2 |
| APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis |
2 |
| Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma |
2 |
| Potentially pathogenic germline CHEK2 c.319+2T > A among multiple early-onset cancer families |
2 |
